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ABSTRACT: A disposable electrochemical test strip for the
quantitative point-of-care (POC) determination of acetaminophen
(paracetamol) in plasma and finger-prick whole blood was
fabricated. The industrially scalable dry transfer process of single-
walled carbon nanotubes (SWCNTs) and screen printing of silver
were combined to produce integrated electrochemical test strips.
Nafion coating stabilized the potential of the Ag reference electrode
and enabled the selective detection in spiked plasma as well as in
whole blood samples. The test strips were able to detect
acetaminophen in small 40 μL samples with a detection limit of
0.8 μM and a wide linear range from 1 μM to 2 mM, well within
the required clinical range. After a simple 1:1 dilution of plasma and
whole blood, a quantitative detection with good recoveries of 79%
in plasma and 74% in whole blood was achieved. These results strongly indicate that these electrodes can be used directly to
determine the unbound acetaminophen fraction without the need for any additional steps. The developed test strip shows promise as
a rapid and simple POC quantitative acetaminophen assay.
■ INTRODUCTION
Acetaminophen (paracetamol) is one of the most widely used
analgesics with antipyretic properties.1 It is readily available,
inexpensive, and better-tolerated than nonsteroidal anti-
inflammatory drugs (NSAIDs).1 It is therefore widely
recommended for the treatment of fever and pain.2
Acetaminophen is also commonly prescribed in combination
with opioids due to its opioid-sparing effect.1 However, unlike
NSAIDs, doses only slightly larger than recommended can
cause hepatotoxicity. Acetaminophen is one of the most
commonly overdosed drugs, and acetaminophen poisoning is
currently the leading cause of acute liver failure in the United
States and Europe.3,4 In the United States alone, the poison
control centers receive over 111 000 consultations related to
acetaminophen and there are 40 000 associated emergency
department cases annually.5 Both intentional and unintentional
exposures to toxic levels of acetaminophen are common.4
The toxicity of acetaminophen is due to the highly reactive
metabolite N-acetyl-p-benzoquinone imine (NAPQI). At
therapeutic doses, acetaminophen is mostly converted to
pharmacologically inactive glucuronide and sulfate, with only
5−10% being oxidized to the toxic metabolite, mainly by
cytochrome P450 (CYP) isozyme 2E1.2 At these concen-
trations, NAPQI is immediately inactivated by conjugation
with glutathione and excreted in urine.5 Toxic doses of
acetaminophen cause a higher proportion of the drug to be
metabolized into NAPQI. The excess NAPQI depletes the
glutathione detoxification pathway after which it starts to form
protein adducts through binding to cysteine groups of cell
proteins.2 This may ultimately lead to liver cell necrosis and
acute liver failure.2 The cellular damage has been found to be
directly related to the dose of acetaminophen.3
Acetaminophen poisoning can be effectively treated with the
glutathione precursor N-acetylcysteine. Unfortunately, acet-
aminophen poisoning shows few and nonspecific symptoms in
the first 24 h.3,6 Furthermore, the N-acetylcysteine treatment is
most effective when initiated within 8−12 h after exposure,5
and after 15 h, the efficacy of the antidote rapidly diminishes.6
For these reasons, the National Academy of Clinical
Biochemistry has endorsed screening for acetaminophen in
all emergency department patients who present with inten-
tional drug ingestion.5 Diagnosis of acetaminophen overdose is
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usually carried out by determining the acetaminophen serum
concentration.7 The Rumack−Matthew nomogram, which
plots the acetaminophen concentration as a function of time
postingestion, is helpful in determining the likelihood of
hepatotoxicity. Serum levels at or above 200 μg/mL (1.323
mM) at 4 h postingestion and 6.25 μg/mL (43.1 μM) at 24 h
postingestion have been found to consistently predict
hepatotoxicity. The line between these points is referred to
as the probable toxicity line. The FDA later required the
addition of a line 25% below the original line to build in some
additional safety.8
In clinical settings, semirapid tests are usually carried out
with spectrophotometric methods because of relative simplicity
and low cost.9,10 Despite these advantages, this method is still
confined to specialized laboratories and is poorly suited for
point-of-care (POC) testing. Moreover, interference causing
both falsely high and low results has been reported with these
methods.9−11 In addition, competitive lateral flow immuno-
assays are also available for the qualitative determination of
acetaminophen. These tests are, however, not quantitative, and
due to high cutoff concentrations, false negatives have been
reported.12 Therefore, the development of a highly mobile,
simple, and quantitative POC assay for screening of
acetaminophen poisoning would be highly beneficial.
Electrochemical detection is relatively simple and inex-
pensive, and the required instrumentation is readily available
and portable. Moreover, the use of screen-printed electrodes
enables highly sensitive detection from small microliter sample
volumes with little or no pretreatment.13 Moreover, capillary
blood from finger-prick collection has been previously shown
to be a reliable sampling matrix for the evaluation of the
pharmacokinetic parameters of acetaminophen.14,15 This
further highlights the suitability of electrochemical methods
for POC screening of acetaminophen poisoning.
Low detection limits in the nanomolar range have been
achieved with several novel electrode materials.16−25 Unfortu-
nately, interference from especially ascorbic (AA) and uric acid
(UA) has been reported at concentrations expected for
biological samples.16,26 Studies have shown that the oxidation
potential of acetaminophen is highly dependent on surface
chemistry27 and there is considerable variation in the oxidation
potential of acetaminophen at different electrodes18,20,22,28 in
the literature. When selectivity is achieved by an anodic shift of
the oxidation peak, however, interference from other
endogenous chemicals is expected.29,30 Recent reports have
shown selective detection of acetaminophen in urine samples
and blood serum. These reports, however, also relied on
sample processing including liquid−liquid extraction, precip-
itation of proteins, and centrifugation as well as considerable
dilution of the sample matrix.19,20 Moreover, Moghaddam et
al.20 reported significant interference in the unextracted urine
sample.
Direct electrochemical detection of acetaminophen from
untreated plasma or whole blood samples has not been
reported. This is likely due to both the interference from
electrochemically active biomolecules and electrode fouling by
proteins. We have recently shown that by combining carbon
electrodes with thin-film Nafion coatings, we can virtually
eliminate the interference from anions, such as AA and UA,
and significantly reduce the matrix effect in the electrochemical
determination of opioids in human plasma.29,30 Moreover,
these results were obtained after only a simple dilution of the
plasma, without precipitation of proteins. Several other works
have also reported sensitive detection of acetaminophen with
Nafion-containing composite electrodes.24−26,31,32 Most of
these electrodes, however, do not show permselective proper-
ties,26,31,32 or the interference of AA and UA was not studied.25
In recent years, single-walled carbon nanotubes (SWCNTs)
have attracted a great deal of attention due to their unique
structure and extraordinary properties, such as large surface
area, mechanical strength, high electrical conductivity, and
electrocatalytic activity.33 It has been shown that SWCNT
network electrodes have low charging current and enhanced
mass transfer, enabling a high signal-to-noise ratio in
electrochemical detection.34 By means of aerosol chemical
vapor deposition (CVD), large areas of porous SWCNT
electrodes with high conductivity and surface area can be
produced. This enables the production of inexpensive
disposable SWCNT electrodes on a wide range of substrates
including polymers. Carbon nanotube-modified screen-printed
electrode strips have also been previously reported.35−38 The
fabrication of such electrodes, however, requires preparation of
special carbon nanotube composite ink formulations or
modification of the electrodes after screen printing. In contrast,
the dry transfer process directly produces a high-surface-area
electrode with high conductivity. This process allows for the
collection of patterned networks that can easily be press-
transferred to produce electrodes without the need for
modification of conventional carbon electrodes.39−41 Alter-
natively, SWCNT thin films can be laser-patterned down to 10
μm by laser ablation without any damage to polymer
substrates. This process can be performed at high throughputs
and is fully roll-to-roll compatible.42
Despite the recent increase in the availability of screen-
printed electrodes, the challenge of fabricating inexpensive,
durable, and reliable miniaturized reference electrodes has
limited their industrial applicability.43 Usually, screen-printed
Ag or Ag/AgCl electrodes give satisfactory performance in
voltammetric electroanalysis. In the screen-printing process, a
layer of Ag is usually first screen-printed followed by an AgCl
layer printed with AgCl ink. It has previously been shown that
Nafion coatings can be used to stabilize the potential of Ag/
AgCl electrodes.44,45 Therefore, we fabricate Ag reference
electrodes, without the second screen-printing step with AgCl
ink.
In this work, we present a simple fully industrially
compatible process for the production of disposable electro-
chemical test strips. We combine dry transfer and laser ablation
patterning of SWCNT with screen printing of silver and slot-
die coating of Nafion to realize highly repeatable electrodes
with a significantly reduced matrix effect in plasma and whole
blood. All of the used techniques are industrially mature and
fully compatible with roll-to-roll processing. We show the
determination of physiologically relevant concentrations of
acetaminophen from only mildly diluted plasma and whole
blood samples obtained by a finger prick.
■ EXPERIMENTAL SECTION
Production of Sensor Strips. The fabrication process of
the disposable electrodes is described in detail in the
Supporting Information, and a step by step fabrication scheme
is shown in Figure S1. Briefly, the SWCNTs were first grown
by aerosol CVD, as discussed in detail in refs 40, 46, and
collected on a filter. An 18 × 26 cm2 SWCNT network was
then press-transferred onto an A4 PET sheet, densified, and
baked for 10 min at 100 °C. The press-transferred SWCNT
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had optical transparency of 71.6% (550 nm) and a sheet
resistance of 73 Ω/sq. SWCNT electrodes made with the same
process have previously been characterized in detail in refs 29,
34. Silver was screen-printed directly on top of the SWCNT to
fabricate reference electrodes and contact pads. SWCNT
electrodes were patterned with a nanosecond pulse laser at
1064 nm wavelength. Finally, the A4 PET sheet was coated
with 117 Nafion (Sigma-Aldrich), diluted to 2.5 wt % with
ethanol, with a slot-die coater (FOM Technologies). Prior to
measurements, strips were cut out and covered with a
poly(tetrafluoroethylene) (PTFE) film (Saint-Gobain Per-
formance Plastics CHR 2255-2) with a prepunched 6 mm
hole.
Characterizations. The thicknesses of the Ag reference
electrode and the SWCNT/Nafion layer were measured with a
scanning electron microscope (SEM). Before imaging, cross-
sectional samples were prepared with focused ion beam (FIB)
milling. Both FIB milling and SEM imaging were carried out
with a FEI Helios NanoLab 600 dual-beam system. Before
milling, the samples were coated with 100 nm gold by
evaporation (InstrumenttiMattila). The cross sections were
milled with 16 kV acceleration voltage in rough milling and
280/460 pA currents. The thickness of the silver lines was also
measured with a profilometer (Dektak 6 M) over several places
of the lines and over the reference electrode.
Electrochemical Measurements. All measurements in a
conventional 50 mL cell were carried out with a Gamry
Reference 600 potentiostat. A three-electrode setup with a Pt
wire counter electrode and a Ag/AgCl [sat. KCl] (Radiometer
Analytical, +0.199 V vs standard hydrogen electrode) reference
electrode placed in a Luggin capillary was used to measure the
potential of the Ag electrode. For the cyclic voltammetry (CV)
measurements performed in the 50 mL cell, the integrated
electrodes of the test strips were connected. In these
measurements, a modified serial ATA cable was used as a
connector. All differential pulse voltammetry (DPV) and CV
experiments with 40 μL drops were carried out with a
PalmSens4 portable potentiostat to simulate a full POC setup.
KCl solutions with different concentrations were prepared
by dissolving KCl (Merk Suprapur) in deionized water (18.2
MΩ−cm) to study the susceptibility of the Ag reference
electrode to the Cl− concentration. Morphine hydrochloride
for interference studies was obtained from the University
Pharmacy, Helsinki, Finland. All other chemicals were
obtained from Sigma-Aldrich. For studying electron transfer,
a 1 mM solution of the outer sphere redox probe Ru(NH3)6
was prepared in 1 M KCl and phosphate-buffered saline (PBS).
The acetaminophen and interferent solutions were prepared in
a pH 7.4 phosphate-buffered saline (PBS) solution. For the
plasma measurements, expired human plasma (Octaplas AB,
Sweden) was received from the blood center of Helsinki
University Hospital Laboratory Services, HUSLAB (Finland).
The plasma samples were diluted with a 1:1 ratio by adding 1
mL of plasma in 1 mL of pH 7.4 PBS. Whole blood was
obtained by a finger prick from a healthy volunteer (plasma
samples from a different person) and collected in 20 μL
calibrated microcapillary tubes (Drummond Scientific Com-
pany). The blood samples were then placed in a 2 mL
Eppendorf and diluted with 20 μL of PBS. The plasma and
whole blood samples with acetaminophen were prepared by
spiking the PBS used for dilution with twice the target
acetaminophen concentration. To avoid clotting, a new whole
blood sample was obtained for each measurement. For each
measurement, a 40 μL drop was placed on the test strip with a
micropipette. An accumulation time of 2.5 min was used for all
measurements. Between measurements, the measured drop
was wiped with tissue paper and the test strip was rinsed with a
PBS drop for 2.5 min before the next drop was placed on the
strip.
■ RESULTS AND DISCUSSION
Characterization. Figure 1 shows the cross-sectional
images acquired from milled areas of (A) the working
electrode and (B) the reference electrode. The overall
thickness of the SWCNT/Nafion layer of the working
electrode can be seen to be approximately 170 nm. A dark
layer with a thickness of 65−75 nm between the SWCNT/
Nafion layer and the Au coating can also be observed likely due
to Nafion. The observation of an SWCNT/Nafion composite
layer is in agreement with a previous study by us,29 suggesting
that the SWCNTs are Nafion-functionalized. The cross section
of the Ag reference electrode shows flat elongated Ag particles
in the few micrometer size range. Thicknesses between 5.9 and
7.2 μm were obtained for the cross sections of the reference
electrodes. Similarly, measurements in different spots of the
silver lines with a contact profilometer gave thicknesses in the
range of 5.5−7 μm. Due to the large roughness, a clear layer of
Nafion cannot be discerned on top of the Ag particles.
Electrochemical Measurements. Performance of
Screen-Printed Ag Quasi-Reference Electrodes. Usually,
quasi-reference electrodes suffer from drifting potentials during
measurements, short lifetimes, long run-in times before the
potential stabilizes, and relatively short shelf lives.43,47 Figure
2A shows the potential vs an Ag/AgCl electrode of both the
uncoated and Nafion-coated Ag reference electrodes in a 0.1 M
PBS solution. Both types of electrodes start at a potential of 84
± 1 mV. The potential of the uncoated electrode, however,
drifts significantly during the measurements and stabilizes only
after approximately 2 h. In contrast, the Nafion-coated
electrodes immediately show a stable potential with no
required run-in time. One Nafion-coated electrode was also
Figure 1. Focused ion beam milled cross sections on the Nafion-
coated (A) working and (B) reference electrodes imaged with
scanning electron microscopy.
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measured for 7.5 h giving a potential of 84.78 ± 0.35 mV. At
no point during the measurement did the potential change
more than ±1 mV as the lowest and highest measured
potentials were 84.07 and 85.39 mV, respectively. A long-term
stability study was also carried out, where a potential drop of
only 9.85 mV was observed over 7 days of immersion in PBS.
The potential stability and drift rate are comparable to those of
screen-printed Ag/AgCl electrodes with much more compli-
cated design with protective layers incorporating a salt matrix
(KCl).47
Nolan et al.45 have previously used Nafion membranes to
stabilize the potential of screen-printed Ag/AgCl electrodes.
Moussy et al.44 have also shown that the potential of a Nafion-
coated Ag/AgCl electrode remained constant for up to 2 weeks
after implantation in a rat. In their study, however, it took 30−
35 min for the potential to stabilize. In contrast, the electrode
in this work immediately produces a stable potential and
remains stable for up to 7 days. These measurements clearly
show that the Nafion-coated electrodes can be used for
voltammetric measurements in POC applications without any
preconditioning. Moreover, one of the four measured electrode
strips was from a different batch that was stored under ambient
conditions for approximately 1.5 years prior to measurements.
This electrode also showed a stable potential of 84.42 ± 0.47
mV during a 3 h measurement, indicating excellent shelf life of
the reference electrode without any packaging of the electrode.
The susceptibility to Cl− concentration was studied by
measuring the potential in KCl solutions with different
concentrations. Figure 2B shows the average potential of
three uncoated and Nafion-coated reference electrodes (5 min
measurement) in different Cl− concentrations as a function of
the logarithm of the Cl− concentration. The uncoated
Figure 2. (A) Potential of the uncoated and Nafion-coated Ag quasi-
reference electrodes vs. Ag/AgCl [sat. KCl] in 0.1 M PBS solution.
(B) Potential as a function of the Cl− concentration in KCl solutions.
The error bars show the standard deviations of measurements with
three different electrodes.
Figure 3. DPVs of increasing concentrations of acetaminophen in (A) PBS, (B) human plasma, and (C) whole blood. (D) Linearization of results
in all measured matrices. The error bars show the standard deviations of four measurements with different electrodes.
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electrodes show a relatively large variation likely due to the
potential drift between the measurements expected based on
the data in Figure 2A. The potential of the Nafion-coated Ag
reference electrodes depends linearly on the logarithm of the
Cl− concentration of the electrolyte with a slope of −33.9 mV/
log[Cl−]. The potential of the noncoated electrode shows less
dependence on the Cl− concentration. While the susceptibility
of the Nafion-coated electrode is lower than that predicted by
the Nernst equation for an Ag/AgCl electrode,47 these results
suggest that the use of the test strip is limited to applications
where the sample Cl− concentration is known. For this reason,
all dilutions are carried out with PBS to avoid changes in the
ionic strength.
Electron Transfer. The electron transfer was studied with
the outer sphere redox probe Ru(NH3)6. Figure S2 shows the
CV measurements with various scan rates in 1 mM Ru(NH3)6
in 1 M KCl with the Nafion-coated electrode. A peak potential
separation (ΔEp) of 68.8 mV (scan rate, 100 mV/s) was
obtained, indicating close to reversible electron transfer. The
increasing peak potential separation with an increasing scan
rate (110 mV with 400 mV/s), however, indicates quasi-
reversible electron transfer. Uncompensated resistance values
of 164.1 ± 25.6 Ω were also measured for six electrodes with a
40 μL PBS solution drop.
Single Drop Analysis of Acetaminophen. Figure S3 shows
the DPV measurements carried out with the sensor strip in a
conventional 50 mL electrochemical cell and with a 40 μL
drop placed directly on the sensor. Background-subtracted
oxidation peak currents of 1.178 and 1.159 μA were measured
for 50 μM acetaminophen in the 50 mL cell and with a 40 μL
drop, respectively. Figure S4 shows DPV measurements with
different pulse amplitudes with a 40 μL drop of human plasma.
A larger pulse amplitude expectedly leads to an improved
sensitivity toward acetaminophen with only a negligible
increase in the background peaks at around 150 and 550
mV. This indicates an improved selectivity toward acetamino-
phen. Because the best signal-to-background-current ratio was
observed with a pulse amplitude of 75 mV, this pulse
amplitude was chosen for all further measurements.
Figure 3 shows the DPV measurements with increasing
acetaminophen concentrations in PBS, plasma, and whole
blood as well as the linearization of the currents. The oxidation
currents scale linearly with the concentration in the range of 1
μM to 2 mM. Correlation coefficients of R2 = 0.9959, R2 =
0.9999, and R2 = 0.9956 were obtained for PBS, plasma, and
whole blood, respectively, indicating high linearity throughout
the physiologically relevant concentration range.7 The limit of
detection (LOD) was calculated as LOD = (3 × σ)/S, where σ
is the standard deviation of three measurements in blank PBS
and S is the sensitivity over the whole linear range. The LOD
was determined separately for four electrodes giving an average
value of 0.819 ± 0.265 μM. The highest LOD was 1.06 μM,
still well below the cutoff concentration used by most clinical
laboratories of approximately 66.15 μM (10 mg/L).12 The
results show that the developed test strip can quantitatively
determine the blood acetaminophen at these levels even after
dilution with PBS and taking into account the lower recovery
in plasma and whole blood.
Based on the slopes in Figure 3D, recoveries of 79 and 74%
were obtained in plasma and whole blood, respectively. The
relative standard deviations (RSDs) of the oxidation currents
over the whole linear range were 4.3, 7.0, and 10.0% in PBS,
plasma, and whole blood, respectively. It should be noted that
the used plasma and whole blood were from different
individuals. It should further be noted that the whole blood
measurements were carried out on three separate days and at
different times of the day without fasting. Due to the larger
variation in the plasma and whole blood measurements in
Figure 3, a recovery test with single measurements of spiked
whole blood samples at three different concentrations was also
carried out with three electrodes at each concentration. The
results are presented in Table 1, showing recoveries of around
74%. RSD values of 7.4, 5.5, and 1.9% were obtained at
concentrations of 50, 100, and 500 μM, respectively. It should
be noted that these results were obtained by drawing finger-
prick whole blood, diluting with an acetaminophen-spiked PBS
solution, and transferring the sample onto the test strip. The
RSD values therefore represent the cumulative error from all of
these steps.
Protein-bound fractions of 20−25% have been previously
reported for acetaminophen.48 The unbound fraction was also
found to be independent of concentration in the clinically
relevant concentration range. Similar results were also obtained
in a recent report,29 where we found recoveries of 61.4 and
41.5% for morphine and codeine, respectively, with a Nafion-
coated SWCNT electrode. These recoveries closely match
previously reported unbound fractions. Banis et al.49 also
concluded that only the free fraction of clozapine, a
benzodiazepine, contributes to the measured electrochemical
signal in bovine serum albumin-containing analyte solutions
with a chitosan-based composite-coated electrode. These
results suggest that the electrodes coated with polymer
membranes can directly determine the unbound acetamino-
phen fraction, without the need for time-consuming equili-
brium dialysis.
As can be seen from Table S1, lower detection limits and
relatively wide linear ranges have previously been reported by
several groups.16−25 However, as is evident from the treatment
nomogram, extreme sensitivity is not required. The works in
Table S1 also rely on time-consuming sample processing,
including precipitation of proteins and considerable dilution, to
reduce matrix effects that significantly increase the estimated
assay time. Moreover, none of them report the detection of
acetaminophen in whole blood. It should also be noted that
further processing is required to obtain serum and plasma
samples from whole blood. In standard operating procedures,
10−15 min of centrifugation is required to obtain plasma and
serum samples.50 For example, Brahman et al.17 centrifuged
the blood samples for 30 min at 4000 rpm to obtain human
serum samples. In addition, around 30−60 min is required for
clotting to obtain high-quality serum samples.50 The protein
precipitation carried out by most works in Table S1 also
requires further chemical treatments and centrifugation. These
sample treatment steps lead to assay times in excess of 45 min
and dilution of the sample by approximately two times. In
contrast, the assay developed in this work can be used for the
determination of the acetaminophen concentration from
Table 1. Recovery Study in Whole Blooda
added found recovery % RSD % (n = 3)
50 36.5 73.1 7.4
100 74.7 74.7 5.5
500 371.8 74.4 1.9
aAverage of three determinations with three different electrodes.
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finger-prick whole blood, only after diluting with equal part
PBS and without the precipitation of proteins in less than 5
min, making it the only electrode applicable in a clinical POC
device.
Passivation. To verify that the lower recoveries in plasma
and whole blood are not due to fouling by proteins, the
passivation of the electrode was studied. First, 1 mM
Ru(NH3)6 was measured in both PBS and human plasma.
Figure S5 shows no apparent passivation of the electrode when
1 mM Ru(NH3)6 is measured in PBS and diluted human
plasma. This result is in line with a similar passivation study
carried out with a Nafion-coated SWCNT electrode in
previous research.29 Furthermore, the electrodes used to
measure 50 μM acetaminophen in whole blood (see Table
1) were also used to measure 50 μM acetaminophen in PBS.
After wiping away the whole blood, washing with a 40 μL drop
of PBS, and confirming that the background returns to that of
blank PBS, a mean peak current of 1.83 ± 0.09 μM was
obtained. This represents a recovery of 101.7%, indicating that
there is no permanent fouling after whole blood measure-
ments. The passivation was further studied in high
concentrations of acetaminophen, by performing 10 consec-
utive DPV scans in plasma and whole blood with 1 mM
acetaminophen. Figure S6 shows the measured oxidation
currents as a function of the scan number (no washing was
carried out between measurements). These measurements
gave RSDs of 3.6% in whole blood and 4.3% in plasma,
indicating that no passivation occurs during 10 measurements.
Interferent Studies. The lack of any matrix effect in the
background currents in Figure 3 shows that no appreciable
interference is caused by endogenous substances. Despite this,
other drugs may cause interference in the determination of
acetaminophen. Therefore, several drugs frequently taken in
concomitant overdose with acetaminophen, including NSAIDs,
caffeine, amoxicillin, and opioids,51 were tested. The opioids
morphine (MO), the active metabolite of codeine and heroin,
and O-desmethyltramadol (ODMT), the active metabolite of
tramadol, have phenol functionalities and are accumulated by
Nafion due to their positive charge. Therefore, these two
opioids were tested for interference. In cases where high
concentrations caused interference, the tolerance limit was
defined as the maximum concentration of the interferent that
caused an error of less than 5% in the acetaminophen
determination. Figure 4 shows the DPV scan in the absence
and presence of a NSAID mix (containing 100 μM ibuprofen,
naproxen, and aspirin), 1 mM salicylic acid (SA), 1 mM
nicotine, 1 mM amoxicillin (Amox), 1 mM caffeine (CAF), 10
μM ODMT, and 2.5 μM MO. It is evident that the NSAID
mix, 1 mM SA, 1 mM Amox, 1 mM nicotine, and 1 mM CAF
did not cause more than 5% interference. Much lower
tolerance limits of 2.5 μM for morphine and 10 μM for
ODMT were obtained. These concentrations, however, are
high compared to the therapeutic levels. Even in fatal cases of
morphine and tramadol poisoning, the concentrations remain
below the tested concentrations at approximately 1.75 and 3.8
μM, respectively.52
■ CONCLUSIONS
We show a mass production compatible fabrication process of
a disposable Nafion-coated electrochemical test strip with
patterned SWCNT electrodes and screen-printed silver quasi-
reference electrodes for the quantitative point-of-care deter-
mination of acetaminophen. The produced silver reference
electrodes show excellent shelf life, long-term stability, and
short hydration time. With this test strip, clinically relevant
detection limits and a linear range for determination of
acetaminophen were achieved. Furthermore, the detection of
acetaminophen was demonstrated in a similar wide concen-
tration range in spiked human plasma and whole blood
obtained through a finger prick. Recoveries closely match the
unbound fraction of acetaminophen in blood, suggesting that
the electrode is measuring exclusively the unbound fraction of
acetaminophen. Aside from mild dilution, no sample treatment
is required and an assay time of less than 5 min is achieved.
Moreover, selectivity was also shown in the presence of several
interferents. These results suggest that the developed test strip
can be used as a highly portable and fast point-of-care assay for
screening of acetaminophen poisoning, requiring only 20 μL of
sample. However, further validation with real patient samples
and parallel measurements with standard laboratory assays are
still needed. Similarly, pharmacokinetic parameters will need to
be evaluated from both venous and capillary finger-prick blood
samples. Further development to enhance the sensitivity,
without compromising the selectivity, or miniaturization of the
active electrode area is also required to reduce the sample size
to 10 μL or below.
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Figure 4. Interference study. (A) DPV scans in blank PBS (black
line), interferent alone (blue line), and interferent + 50 μM
acetaminophen (red line). (B) Background-subtracted peak current
for 50 μM acetaminophen (ACE) alone (red) and acetaminophen in
the presence of the interferent (blue). The error bar represents a 5%
error defined as the tolerance limit. The DPV scans in (A) have been
offset for clarity.
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Detailed description of the test strip fabrication process,
comparison of measurements in a 50 mL cell vs 40 μL
drop; cyclic voltammogram of 1 mM Ru(NH3)6 in 1 M
KCl, optimization of DPV parameters in plasma,
passivation study with Ru(NH3)6 and acetaminophen,
and comparison of electroanalytical methods for the
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